These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

64 related items for PubMed ID: 967429

  • 41. Resistance of Bifidobacteria and Lactobacilli to tobramycin.
    Heine W, Mohr C, Ullrich S, Plath C, Uhlemann M.
    Eur J Pediatr; 1996 May; 155(5):421. PubMed ID: 8741044
    [No Abstract] [Full Text] [Related]

  • 42. Aminoglycoside antibiotics. X. chemical conversion of kanamycin B to kanamycin C and 6'-deoxy-kanamycin C.
    Toda S, Nakagawa S, Naito T.
    J Antibiot (Tokyo); 1977 Nov; 30(11):1002-3. PubMed ID: 591453
    [No Abstract] [Full Text] [Related]

  • 43. [Chemotherapy of open fracture with special reference to distribution of antibiotics. 1. Experimental study on distribution of Kanendomycin (2'-amino-2'-deoxy-kanamycin) in the bone marrow and blood].
    Kondo S.
    Nihon Seikeigeka Gakkai Zasshi; 1970 Apr; 44(4):313-9. PubMed ID: 5464944
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Preparation and some microbiological properties of novel kanamycin-glucoside derivatives.
    Suzuki Y, Ohmori H, Hashimoto Y, Noguchi T.
    J Antibiot (Tokyo); 1979 Jul; 32(7):753-5. PubMed ID: 541269
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Human serum albumin for in-vitro tests.
    Bakhtiar M, Selwyn S.
    J Antimicrob Chemother; 1985 Jun; 15(6):789-90. PubMed ID: 4030543
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. [Comparative in vitro activity of dibekacin, gentamicin and tobramycin on 617 bacterial strains].
    Coulet M, Brun Y, Forey F, Fleurette J.
    Nouv Presse Med; 1982 Nov 18; 11(46):3391-5. PubMed ID: 7155846
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Comparative study of in vitro antimicrobial activity and human pharmacokinetics of dibekacin and tobramycin.
    Verbist L, Tjandramaga TB, Mullie A, Van Hecken A, Verbesselt R, De Schepper PJ.
    Acta Clin Belg; 1982 Nov 18; 37(3):148-57. PubMed ID: 7124274
    [No Abstract] [Full Text] [Related]

  • 55. Chemical modification of tobramycin.
    Igarashi K.
    Jpn J Antibiot; 1979 Dec 18; 32 Suppl():S187-94. PubMed ID: 398902
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. [Comparative in vitro activity of dibekacin, gentamicin and tobramycin on 617 bacterial strains].
    Coulet M, Brun Y, Forey F, Fleurette J.
    Nouv Presse Med; 1982 Nov 18; 11(46):3391-5. PubMed ID: 7155846
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Resistance to aminoglycoside antibiotics of gram-negative bacilli isolated in Canadian hospitals.
    Duncan IB, Cheung EY, Haldane EV, Jackson FL, McNaughton RD, Morisset RA, Noble MA, Rennie RP, Ronald AR, Smith JA.
    Can Med Assoc J; 1981 May 01; 124(9):1165-7. PubMed ID: 7237336
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.